| Product NDC: | 45802-112 |
| Proprietary Name: | mupirocin |
| Non Proprietary Name: | Mupirocin |
| Active Ingredient(s): | 20 mg/g & nbsp; Mupirocin |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 45802-112 |
| Labeler Name: | Perrigo New York Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065123 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091030 |
| Package NDC: | 45802-112-22 |
| Package Description: | 1 TUBE in 1 CARTON (45802-112-22) > 22 g in 1 TUBE |
| NDC Code | 45802-112-22 |
| Proprietary Name | mupirocin |
| Package Description | 1 TUBE in 1 CARTON (45802-112-22) > 22 g in 1 TUBE |
| Product NDC | 45802-112 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Mupirocin |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 20091030 |
| Marketing Category Name | ANDA |
| Labeler Name | Perrigo New York Inc |
| Substance Name | MUPIROCIN |
| Strength Number | 20 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | RNA Synthetase Inhibitor Antibacterial [EPC],RNA Synthetase Inhibitors [MoA] |